Saatja: Obon Roger <
[email protected]>
Saaja: Esindus EL juures üldaadress, Nominations
Teema: Estonia-2020-09-29-Nomination invitation for CAT member
For the attention of HE Mr Rein Tammsaar,
Your Excellency,
Please find attached a letter from the Executive Director of the European Medicines Agency regarding the nomination of representatives in the Committee for Advanced Therapies (CAT).
Kind Regards,
[3-EMA banner - option 1]<https://www.ema.europa.eu/en/about-us/history-ema>
Roger Obon
Experts and Declarations of Interests Management
Meeting Secretariat Office
Committees and Quality Assurance Department
European Medicines Agency
Domenico Scarlattilaan 6 | 1083 HS Amsterdam | The Netherlands
Telephone +31 (0)88 781 6763
[email protected]<mailto:
[email protected]> | www.ema.europa.eu<https://www.ema.europa.eu/en> | For directions, see How to find us<https://www.ema.europa.eu/en/about-us/contact/how-find-us>
Follow us: [Twitter-icon] <https://twitter.com/EMA_News> [RSS-icon] <https://www.ema.europa.eu/en/news-event/rss-feeds> [Youtube-icon] <https://www.youtube.com/user/emainfo>
This message and any attachment contain information which may be confidential or otherwise protected from disclosure. It is intended for the addressee(s) only and should not be relied upon as legal advice unless it is otherwise stated. If you are not the intended recipient(s) (or authorised by an addressee who received this message), access to this e-mail, or any disclosure or copying of its contents, or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you have received this e-mail in error, please inform the sender immediately.
P Please consider the environment before printing this e-mail
Classified as confidential by the European Medicines Agency
________________________________________________________________________
This e-mail has been scanned for all known viruses by European Medicines Agency.
________________________________________________________________________
Saatja: Webdesktop <
[email protected]>
Saadetud: 01.10.2020 13:55
Adressaat: SM Info <
[email protected]>; info ravimiamet ee <
[email protected]>;
Elen Ohov <
[email protected]>
Koopia: <
[email protected]>
Teema: Webdesktop: Kiri nr 14-4/911 / Esindaja nimetamine Euroopa
Ravimiameti (EMA) uudsete ravimite komiteesse (CAT)
Tere!Edastan EMA kirja. Palun andke enne 13.11.2020 EV AEEL-le teada
(
[email protected], cc:
[email protected]), kas me pikendame praeguse
liikme mandaati või nimetame uue.Reg. number: 14-4/911Reg. kuupäev:
01.10.2020Sisu: Esindaja nimetamine Euroopa Ravimiameti (EMA) uudsete
ravimite komiteesse (CAT) / Nomination of representatives in the
Committee for Advanced Therapies (CAT) of the European Medicines
AgencyHeade soovidegaTiiu Noobelsekretär EV AEEL juures*** TÄHELEPANU ***
See e-kiri (kaasa arvatud manused) on mõeldud ainult e-kirja
adressaatidele ning võib sisaldada ametialaseks kasutamiseks ettenähtud
teavet. Teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata
ega mistahes viisil kõrvalistele isikutele avaldada. Juhul, kui Te olete
saanud käesoleva e-kirja eksituse tõttu, palun teavitage sellest kohe
saatjat ning kustutage e-kiri oma arvutist.